We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results:1-10 of 41

La publicité des médicaments dans le contexte des médias sociaux
  • Gowling WLG
  • USA, Canada
  • January 29 2016

Tant aux États-Unis qu’au Canada, la publicité des produits pharmaceutiques d’ordonnance est fortement réglementée et peut poser plusieurs défis qui


Drug advertising in the context of social media
  • Gowling WLG
  • USA, Canada
  • January 22 2016

Both in the U.S. and in Canada, advertising of prescription pharmaceutical products is highly regulated and can raise various challenges, which are


U.S. FDA contemplates new rules for internet-delivered health information
  • Gowling WLG
  • USA
  • December 3 2009

In recognition of the increasing use of the Internet by consumers for health-related information, the FDA is seeking to determine whether it needs to regulate the promotion of drugs and medical devices on the Internet.


U.S. bill considers access to Canadian pharmaceuticals
  • Gowling WLG
  • USA, Canada
  • July 27 2009

Recently, the U.S. Senate amended the $43 billion Department of Homeland Securities Bill to allow Americans to purchase prescription drugs from Canadian internet pharmacies.


U.S. FDA finds consumers continue to buy potentially dangerous drugs over the internet
  • Gowling WLG
  • USA
  • July 13 2007

On July 2, 2007, the FDA again warned consumers about the dangers of buying medications over the Internet.




Scott E. Foster
  • Gowling WLG

Alex Zavaglia
  • Gowling WLG

Belinda A. Bain
  • Gowling WLG